Resistance to linezolid in a methicillin-susceptible Staphylococcus aureus clinical isolate without previous exposure to oxazolidinones

International Journal of Medical Microbiology

Volumn 302, Issue 3, 2012, Pages 145-147

  Quiles Melero, Immaculada ^a   García Perea, Adela ^a   de Pablos, Manuela ^a   Gómez Gil, Rosa ^a   Mingorance, Jesús ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

Author keywords

Antibiotic resistance; Linezolid; Methicillin; Staphylococcus aureus

Indexed keywords

AMPICILLIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; OXACILLIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; RIFAMPICIN; RNA; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

AGED; AMBULATORY CARE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE REPORT; DRUG EXPOSURE; ENTEROCOCCUS FAECIUM; FEMALE; GENE FREQUENCY; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTENSIVE CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MUTATION; PHENOTYPE; PYROSEQUENCING; REVERSE TRANSCRIPTION; SURGICAL INFECTION; SURGICAL WOUND; TREATMENT DURATION;

ACETAMIDES; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; METHICILLIN; MICROBIAL SENSITIVITY TESTS; OUTPATIENTS; OXAZOLIDINONES; POINT MUTATION; RNA, RIBOSOMAL, 23S; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION;

EID: 84862335401     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2012.03.001     Document Type: Article

References (19)

1. ® Annual Appraisal of Potency and Spectrum program. Diagn. Microbiol. Infect. Dis. 2010, 68:459-467.
2. Bonora M.G., Ligozzi M., Luzzani A., Solbiati M., Stepan E., Fontana R. Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25:197-198.
3. Enright M.C., Day N.P., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 2000, 38:1008-1015.
4. García-González C., García-Bujalance S., Ruiz-Carrascoso G., Arribas J.R., González-García J., Bernardino J.I., Pascual-Pareja J.F., Martínez-Prats L., Delgado R., Mingorance J. Detection and quantification of the K103N mutation in HIV reverse transcriptase by pyrosequencing. Diagn. Microbiol. Infect. Dis. 2011, 72:90-96.
5. Gómez-Gil R., Romero-Gómez M.P., García-Arias A., Ubeda M.G., Busselo M.S., Cisterna R., Gutiérrez-Altés A., Mingorance J. Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital. Diagn. Microbiol. Infect. Dis. 2009, 65:175-179.
6. Jones R.N., Della-Latta P., Lee L.V., Biedenbach D.J. Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program. Diagn. Microbiol. Infect. Dis. 2002, 42:137-139.
7. Kehrenberg C., Schwarz S. Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates. Antimicrob. Agents Chemother. 2006, 50:1156.
8. Livermore D.M. Linezolid in vitro: mechanism and antibacterial spectrum. J. Antimicrob. Chemother. 2003, 51(Suppl. 2):ii9-ii16.
9. Locke J.B., Hilgers M., Shaw K.J. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob. Agents Chemother. 2009, 53:5265-5274.
10. Meka V.G., Gold H.S., Cooke A., Venkataraman L., Eliopoulos G.M., Moellering R.C., Jenkins S.G. Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus. J. Antimicrob. Chemother. 2004, 54:818-820.
11. Mendes R.E., Deshpande L.M., Farrell D.J., Spanu T., Fadda G., Jones R.N. Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. J. Antimicrob. Chemother. 2010, 65:2329-2335.
12. National Committee for Clinical Laboratory Standards Performance Standards for Antimicrobial Susceptibility Testing. Document M100-S16 2006, NCCLS, Wayne, PA.
13. Pillai S., Sakoulas G., Wennersten C. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J. Infect. Dis. 2002, 3:1603-1607.
14. Rahim S., Pillai S.K., Gold H.S., Venkataraman L., Inglima K., Press R.A. Resistant Enterococcus faecium infection in patients without prior exposure to linezolid. Antimicrob. Agents Chemother. 2003, 36:146-148.
15. Sinclair A., Arnold C., Woodford N. Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in enterococci. Antimicrob. Agents Chemother. 2003, 47:3620.
16. Toh S.M., Xiong L., Arias C.A., Villegas M.V., Lolans K., Quinn J., Mankin A.S. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol. Microbiol. 2007, 64:1506-1514.
17. Tsakris A., Pillai S.K., Gold H.S., Thauvin-Eliopoulos C., Venkataraman L., Wennersten C., Moellering R.C., Eliopoulos G.M. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus. J. Antimicrob. Chemother. 2007, 60:649-651.
18. Vindel A., Trincado P., Gomez E., Cabrera R., Boquete T., Sola C., Valdezate S., Saez-Nieto J. Prevalence and evolution of methicillin-resistant Staphylococcus aureus in Spanish hospitals between 1996 and 2002. J. Clin. Microbiol. 2006, 44:266.
19. Xiong L., Kloss P., Douthwaite S., Andersen N.M., Swaney S., Shinabarger D.L., Mankin A.S. Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action. J. Bacteriol. 2000, 182:5325-5331.